Literature DB >> 24448565

Uveal effusion as a mechanism of bilateral angle-closure glaucoma induced by chlorthalidone.

James R Singer1, Zachary D Pearce, Scott J Westhouse, Karl J Siebert.   

Abstract

PURPOSE: To report a novel case of acute bilateral uveal effusions, angle closure, and acute myopia induced by administration of chlorthalidone.
METHODS: Case report.
RESULTS: Bilateral shallow anterior chambers, high intraocular pressure, and a myopic shift were encountered in a patient 1 week after initiation of chlorthalidone. Ultrasound evaluation revealed bilateral ciliochoroidal effusions, appositional angle closure, and suspected ciliary body edema. Cessation of chlorthalidone, in addition to administration of cycloplegics and ocular antihypertensives, resulted in prompt resolution of this idiosyncratic reaction.
CONCLUSIONS: The antihypertensive medication chlorthalidone may cause bilateral uveal effusions inducing acute angle-closure glaucoma and acute myopia.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 24448565     DOI: 10.1097/IJG.0000000000000037

Source DB:  PubMed          Journal:  J Glaucoma        ISSN: 1057-0829            Impact factor:   2.503


  4 in total

1.  Bilateral uveal effusions in a 23-year-old man.

Authors:  Karen W Jeng-Miller; Eric D Gaier; Angela V Turalba
Journal:  Digit J Ophthalmol       Date:  2018-05-22

2.  Uveal effusion following acute primary angle-closure: a retrospective case series.

Authors:  Jian-Gang Yang; Jian-Jun Li; Hua Tian; Yan-Hong Li; Yu-Jing Gong; An-Le Su; Na He
Journal:  Int J Ophthalmol       Date:  2017-03-18       Impact factor: 1.779

3.  Bilateral, Simultaneous, Acute Angle Closure Glaucoma in Pseudophakia Induced by Chlorthalidone.

Authors:  Indra Durai; Mrunali Mohan Dhavalikar; Chandran Prem Anand; Venkatraman Ganesh; Ramaswami Krishnadas
Journal:  Case Rep Ophthalmol Med       Date:  2016-05-05

Review 4.  Drug-induced Acute Angle-closure Glaucoma: A Review.

Authors:  Michael C Yang; Ken Y Lin
Journal:  J Curr Glaucoma Pract       Date:  2019 Sep-Dec
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.